目前关于andrographolide在癌症中的分子机制的证据
Dharam Chand Attri1, Praveen Dhyani2, Vijay Laxmi Trivedi3
1Department of Botany, Central University of Jammu, Rahya-Suchani (Bagla)-181143, Jammu and Kashmir, India.
Current medicinal chemistry
|June 13, 2024
概括
安德罗格拉福利德是来自Andrographis paniculata的天然化合物,显示出作为癌症治疗的希望. 它抑制癌症生长和扩散到各种癌症,没有报告的副作用,为传统疗法提供了潜在的替代方案.
科学领域:
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 癌症是全球死亡的主要原因,传统治疗面临挑战和副作用.
- 对于替代性癌症治疗方法的需求日益增长,特别是那些来自自然来源的替代性癌症治疗方法.
- 二次代谢产物因其在开发新型抗癌药物的潜力而得到认可.
研究的目的:
- 审查Andrographolide的抗癌潜力,这是Andrographis paniculata的一个代谢物.
- 探索Andrographolide的作用机制及其对各种癌症的疗效.
- 评估Andrographolide作为一种具有化学预防性质的潜在天然抗瘤剂.
主要方法:
- 文献评论专注于安德罗格拉福利德的抗癌性质.
- 对Andrographolide对癌细胞增殖,转移和亡的影响详细研究的分析.
- 对Andrographolide对癌症信号通路的影响研究的审查.
主要成果:
- 安德罗格拉福利德通过抑制多个信号通路,显示出显著的抗癌活性.
- 该化合物在各种癌症类型中表现出抗增殖,抗转移和亡作用.
- 安德罗格拉福利德作为一种具有有利副作用概况的化学预防剂具有前景.
结论:
- 安德罗格拉福利德是癌症治疗的有前途的天然化合物,与传统疗法相比,它具有潜在的优势.
- 它能够准多种癌症途径,并且缺乏副作用,这凸显了它的治疗价值.
- 进一步的研究和临床研究对于验证Andrographolide在癌症治疗中的有效性,安全性和最佳应用至关重要.
关键词:
安德罗格拉福利德 (Andrographolide) 是一种色蛋白质.这是一种抗癌药物.灭症 (apoptosis) 是一种死亡的过程.细胞信号通路. 细胞信号通路.移民 移民 迁移 迁移分子机制的分子机制.它们的扩散和扩散.更多相关视频
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


